Challenges to the development of antigen-specific breast cancer vaccines (Q24793404)

6 July 2017

1 reference

23 December 2020

Challenges to the development of antigen-specific breast cancer vaccines (English)

1 reference

6 July 2017

1 reference

inferred from abstract

1 reference

23 December 2020

1 reference

23 December 2020

M J Scanlan

1

1 reference

6 July 2017

D Jäger

series ordinal

2

1 reference

6 July 2017

language of work or name

English

0 references

publication date

11 January 2001

6 references

6 July 2017

13 March 2019

3 April 2019

20 June 2019

17 June 2019

23 December 2020

Breast Cancer Research

6 references

6 July 2017

13 March 2019

3 April 2019

20 June 2019

17 June 2019

23 December 2020

3

1 reference

6 July 2017

issue

2

1 reference

6 July 2017

page(s)

95-98

1 reference

Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Human neoplasms elicit multiple specific immune responses in the autologous host

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Enhancement of antitumor immunity by CTLA-4 blockade

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Induction of primary NY-ESO-1 immunity: CD8 T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1 cancers.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

p53 Antibodies in the sera of patients with various types of cancer: a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Dendritic cells: at the clinical crossroads

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

The new vaccines: building viruses that elicit antitumor immunity.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Mutations in p53 as potential molecular markers for human breast cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Carcinoembryonic antigen as a target for cancer vaccines

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

T cell defined tumor antigens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139438

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

28 November 2018

1 reference

Recombinant Listeria monocytogenes cancer vaccines

21 January 2018

1 reference

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

21 January 2018

1 reference

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8 cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

21 January 2018

1 reference

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

21 January 2018

2 references

21 January 2018

12 December 2020

Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial

1 reference

12 December 2020

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression

1 reference

12 December 2020

Modulation of B16 melanoma growth and metastasis by anti-transforming growth factor beta antibody and interleukin-2

1 reference

12 December 2020

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR278

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference

6 July 2017

1 reference